Avinger Inc. (NASDAQ:AVGR) hit a new 52-week low during mid-day trading on Thursday . The company traded as low as $5.00 and last traded at $5.05, with a volume of 144,573 shares. The stock had previously closed at $5.16.

A number of equities research analysts have issued reports on AVGR shares. Zacks Investment Research downgraded shares of Avinger from a “hold” rating to a “sell” rating in a research note on Monday, May 9th. Canaccord Genuity reiterated a “buy” rating on shares of Avinger in a research note on Tuesday, July 12th. Finally, BTIG Research reiterated a “buy” rating and set a $18.00 price objective on shares of Avinger in a research note on Friday, July 15th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $18.75.

The firm’s 50 day moving average price is $9.39 and its 200-day moving average price is $11.88. The company’s market cap is $62.70 million.

Avinger (NASDAQ:AVGR) last issued its quarterly earnings results on Wednesday, May 4th. The medical device company reported ($1.28) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($1.17) by $0.11. Analysts anticipate that Avinger Inc. will post ($4.26) earnings per share for the current year.

In other Avinger news, Director Donald A. Lucas sold 9,309 shares of the company’s stock in a transaction dated Friday, May 6th. The shares were sold at an average price of $12.58, for a total transaction of $117,107.22. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, VP John D. Simpson acquired 32,500 shares of the company’s stock in a transaction on Wednesday, July 20th. The shares were acquired at an average cost of $6.28 per share, for a total transaction of $204,100.00. The disclosure for this purchase can be found here.

A hedge fund recently bought a new stake in Avinger stock. Thornburg Investment Management Inc. acquired a new stake in shares of Avinger Inc. (NASDAQ:AVGR) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 52,792 shares of the medical device company’s stock, valued at approximately $1,199,000. Thornburg Investment Management Inc. owned about 0.42% of Avinger as of its most recent SEC filing.

Avinger, Inc is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses to introduce products based on its lumivascular platform, which is an intravascular image-guided system.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.